WITHDRAWN: Oral sumatriptan for acute migraine

The Cochrane Database of Systematic Reviews
D C McCrory, R N Gray

Abstract

Migraine is a common neurovascular disorder characterized by recurrent episodes of disabling headache, autonomic nervous system dysfunction, and, in some patients, neurological aura symptoms. Sumatriptan is one of a class of selective serotonin 5-hydroxytryptamine (5-HT1B/1D) agonists (triptans) thought to relieve migraine attacks by several mechanisms, including cranial vasoconstriction and peripheral and central neural inhibition. To describe and assess the evidence from randomized controlled trials (RCTs) concerning the efficacy and tolerability of oral sumatriptan for the treatment of a single acute attack of migraine in adults. We searched the Cochrane Central Register of Controlled Trials (Cochrane Library, Issue 4, 2001), MEDLINE (1966 through November 2001), and reference lists of articles and books. We included double-blind RCTs comparing oral sumatriptan (100 mg, 50 mg, 25 mg) with placebo, no intervention, other drug treatments, behavioral therapy, or physical therapy for the treatment of an acute attack of migraine in adults. Trials comparing different doses of sumatriptan or dosing regimens were also included. Outcomes considered were: 2-hour pain-free response, headache relief/headache intensity, and functional di...Continue Reading

References

Feb 1, 1992·Cephalalgia : an International Journal of Headache·M Banerjee, L J Findley
Sep 28, 1991·Lancet·P J GoadsbyJ W Lance
Nov 12, 1994·BMJ : British Medical Journal·K DickersinC Lefebvre
Oct 1, 1994·Cephalalgia : an International Journal of Headache·M D FerrariG Nappi
Sep 1, 1994·Archives of Family Medicine·R K CadyT W Littlejohn
Jan 1, 1994·Journal of Neurology·G NappiO Zerbini
May 1, 1994·The American Journal of Emergency Medicine·E Hay
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Aug 1, 1996·QJM : Monthly Journal of the Association of Physicians·R J ScottG I McLaren
Feb 1, 1997·Cephalalgia : an International Journal of Headache·K Gruffydd-JonesD B Price
Aug 1, 1997·Cephalalgia : an International Journal of Headache·H A CarpayP G Mulder
Jun 7, 1992·PharmacoEconomics·J T OsterhausJ R Plachetka
Apr 29, 1999·Archives of Internal Medicine·X H HuM L Berger
May 19, 2000·Cephalalgia : an International Journal of Headache·G GeraudR Sweet
Nov 15, 2000·Cephalalgia : an International Journal of Headache·G M DaviesR Lipton
Feb 13, 2001·Cephalalgia : an International Journal of Headache·P Tfelt-HansenUNKNOWN International Headache Society Clinical Trials Subcommittee
Apr 5, 2001·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G BussoneC Benassuti
May 1, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K Gruffyd-JonesD S Millson
Jun 1, 2001·European Neurology·J PascualUNKNOWN Rizatriptan-Sumatriptan Preference Study Group
Sep 29, 2001·Headache·E LoderUNKNOWN Rizatriptan Protocol 060 Study Group

❮ Previous
Next ❯

Citations

Sep 22, 2018·PloS One·Michael Mbithi MutuaThomas Noel Ochieng Achia
Mar 8, 2016·British Journal of Clinical Pharmacology·Charles KhouriMatthieu Roustit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

The Cochrane Database of Systematic Reviews
D C McCrory, R N Gray
Current Pain and Headache Reports
Giorgio Lambru, Manjit Matharu
© 2022 Meta ULC. All rights reserved